BeOne Medicines (ONC) Net Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,058.00 |
| Dec 31, 2025 | -440.00 |
| Sep 30, 2025 | 167.00 |
| Jun 30, 2025 | 706.00 |
| Mar 31, 2025 | 1,358.00 |
| Dec 31, 2024 | -135.00 |
| Sep 30, 2024 | 84.00 |
| Jun 30, 2024 | 2,045.00 |
| Mar 31, 2024 | 2,452.00 |
| Dec 31, 2023 | -8,551.00 |
| Sep 30, 2023 | 9,160.00 |
| Jun 30, 2023 | 1,378.00 |
| Mar 31, 2023 | 3,935.00 |
| Dec 31, 2022 | 2,667.00 |
| Sep 30, 2022 | 2,179.00 |
| Jun 30, 2022 | -2,369.00 |
| Mar 31, 2022 | 13,411.00 |
| Dec 31, 2021 | -6,382.00 |
| Sep 30, 2021 | 10,802.00 |
| Jun 30, 2021 | -33,122.00 |
| Mar 31, 2021 | 51,119.00 |
| Dec 31, 2020 | -2,181.00 |
| Sep 30, 2020 | 4,953.00 |
| Jun 30, 2020 | 20,158.00 |
| Mar 31, 2020 | -1,932.00 |
| Dec 31, 2019 | -6,318.00 |
| Sep 30, 2019 | -57,812.00 |
| Jun 30, 2019 | 16,491.00 |
| Mar 31, 2019 | 24,541.00 |
| Dec 31, 2018 | -18,868.00 |
| Sep 30, 2018 | 657.00 |
| Jun 30, 2018 | 2,429.00 |
| Mar 31, 2018 | 30,423.00 |
| Dec 31, 2017 | -67,889.00 |
| Jun 30, 2016 | -288,864.00 |
| Mar 31, 2016 | -266,714.00 |
| Dec 31, 2015 | 43,178.00 |
| Sep 30, 2015 | -60,565.00 |
| Jun 30, 2015 | 33,177.00 |